Harnessing cell-free DNA testing to combat transplant rejection | Natera
Автор: WebsEdgeMedicine
Загружено: 2025-07-31
Просмотров: 20120
Prospera, developed by Natera, is a proprietary donor-derived cell-free DNA (dd-cfDNA) technology which offers early warning signs of transplant rejection for kidney, heart and lung. Catching transplant rejection as soon as possible can help providers develop a treatment plan to best protect the donated organ.
https://www.natera.com/organ-health/
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: